Radiologists in vacation mode.
[[{"type":"media","view_mode":"media_crop","fid":"27416","attributes":{"alt":"","class":"media-image","id":"media_crop_7781186625218","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2657","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 340px; width: 440px;","title":" ","typeof":"foaf:Image"}}]]
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.